Vanoxerine, a new drug for terminating atrial fibrillation and flutter
about
Oral vanoxerine prevents reinduction of atrial tachyarrhythmias: preliminary resultsVanoxerine: cellular mechanism of a new antiarrhythmicQuantitative Profiling of the Effects of Vanoxerine on Human Cardiac Ion Channels and its Application to Cardiac Risk.Mechanisms of termination and prevention of atrial fibrillation by drug therapy.Antiarrhythmic Drug Therapy for Rhythm Control in Atrial Fibrillation.
P2860
Vanoxerine, a new drug for terminating atrial fibrillation and flutter
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Vanoxerine, a new drug for terminating atrial fibrillation and flutter
@ast
Vanoxerine, a new drug for terminating atrial fibrillation and flutter
@en
Vanoxerine, a new drug for terminating atrial fibrillation and flutter
@nl
type
label
Vanoxerine, a new drug for terminating atrial fibrillation and flutter
@ast
Vanoxerine, a new drug for terminating atrial fibrillation and flutter
@en
Vanoxerine, a new drug for terminating atrial fibrillation and flutter
@nl
prefLabel
Vanoxerine, a new drug for terminating atrial fibrillation and flutter
@ast
Vanoxerine, a new drug for terminating atrial fibrillation and flutter
@en
Vanoxerine, a new drug for terminating atrial fibrillation and flutter
@nl
P2093
P1476
Vanoxerine, a new drug for terminating atrial fibrillation and flutter
@en
P2093
Albert L Waldo
Antonio E Lacerda
Arthur M Brown
Celeen M Khrestian
Kyungmoo Ryu
Naomichi Matsumoto
P2860
P356
10.1111/J.1540-8167.2009.01622.X
P407
P577
2010-03-01T00:00:00Z